Æterna ZentarisのQuick ratio
Æterna ZentarisのQuick ratioは何ですか。
Æterna Zentaris, Inc.のQuick ratioは5.93です。
Quick ratioの定義は何ですか。
当座比率は、短期債務を即座に満たすために迅速な資産を使用する企業の能力を測定する流動性比率です。
The quick ratio is the ratio between quick or liquid assets and current liabilities. Quick assets include those current assets that presumably can be quickly converted to cash at close to their book values. A normal liquid ratio is considered to be 1. A company with a quick ratio of less than 1 cannot at the time fully pay its current liabilities or short-term obligations. This ratio is considered to be a much reliable tool for assessment of liquidity position of companies.
TSXのセクタHealth CareにおけるQuick ratioの企業と比べるÆterna Zentaris
Æterna Zentarisは何をしますか。
Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests. Its lead product is macimorelin, an orally available peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of adult growth hormone deficiency and childhood-onset growth hormone deficiency, as well as oncology indications. The company markets macimorelin under the Macrilen brand name. Aeterna Zentaris Inc. has a license agreement with University Wuerzburg to research, develop, manufacture, and sell a potential COVID-19 vaccine; development, manufacture, and commercialization of the treatment for neuromyelitis optica spectrum disorder; and to develop human 3D intestinal tissue models to study infection biology; and for pre-clinical development towards the potential treatment of Parkinson's disease. It also has a license agreement with Consilient Health Ltd., Novo Nordisk Novo Nordisk Health Care AG, and NK MEDITECH Ltd. for the development and commercialization of macimorelin in the United States and Canada, as well as The University of Sheffield, the United Kingdom for the research, development, manufacture, and commercialization of parathyroid hormone fusion polypeptides for the treatment of primary hypoparathyroidism. Aeterna Zentaris Inc. was incorporated in 1990 and is headquartered in Summerville, South Carolina.
Æterna Zentarisと類似のquick ratio
- Palantir TechnologiesのQuick ratioは5.92です。
- Luminex CorpのQuick ratioは5.92です。
- Probi AB (publ)のQuick ratioは5.92です。
- Marker TherapeuticsのQuick ratioは5.92です。
- FinVolutionのQuick ratioは5.93です。
- Paradigm BiopharmaceuticalsのQuick ratioは5.93です。
- Æterna ZentarisのQuick ratioは5.93です。
- Parkway Minerals NLのQuick ratioは5.93です。
- CocoonのQuick ratioは5.93です。
- High Grade MetalsのQuick ratioは5.93です。
- Hifood CoのQuick ratioは5.94です。
- Camino MineralsのQuick ratioは5.94です。
- artec technologies AGのQuick ratioは5.94です。